facebook
eISSN: 2084-9893
ISSN: 0033-2526
Dermatology Review/Przegląd Dermatologiczny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2021
vol. 108
 
Share:
Share:
abstract:
Review paper

Current options and perspectives for the topical treatment of atopic dermatitis

Roman J. Nowicki
1
,
Elżbieta Grubska-Suchanek
1
,
Magdalena Trzeciak
1
,
Aleksandra Wilkowska
1

  1. Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, Gdansk, Poland
Dermatol Rev/Przegl Dermatol 2021, 108, 117-125
Online publish date: 2021/06/28
View full text Get citation
 
PlumX metrics:
Atopic dermatitis is one of the most common chronic and recurrent skin conditions, characterized by a complex genetic background, most commonly occurring in children. Its prevalence is still increasing. Despite existing methods of therapy (emollients, wet-wrap treatment, topical glucocorticoids, topical calcineurin inhibitors, antiseptics, antibiotics, phototherapy, elimination of irritants, patient education), the number of available topical preparations for the treatment of this chronic disease is limited. Topical glucocorticoids are the mainstay of the treatment of inflammatory changes. Calcineurin inhibitors should not be used under the age of two, and in the remaining patients, topical calcineurin inhibitors constitute the second-line therapy. Glucocorticoids can only be used for a strictly defined period of time and become gradually less effective during a long-term treatment (tachyphylaxis). Introduction of new, safe, topical preparations for the treatment of this chronic disease is imperative.
keywords:

atopic dermatitis, wet-wrap treatment, crisaborole, JAK-STAT inhibitors



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.